C

Crinetics Pharmaceuticals

D
CRNX
USD
1.13
(2.1414%)
Market Closed
24,740.00
Volume
-3.66
EPS
-
Div Yield
-14.335106
P/E
4,313,919,379.00
Market Cap
Today
2.1414%
1 Week
5.191%
1 Month
1.871%
6 Months
19.433%
12 Months
83.271%
Year To Date
51.660%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
A
ARWR
0.35
(1.6851%)
USD
D
DRNA
(%)
USD
A
ARCT
0.49
(2.3833%)
USD
T
TRIL
(%)
USD
M
MRTX
(%)
USD
F
FATE
0.12
(3.0928%)
USD
A
ARVN
0.63
(2.522%)
USD
R
RYTM
0.8
(1.4898%)
USD
B
BLUE
-0.0046
(-0.9287%)
USD
M
MGTX
0.07
(1.6317%)
USD

Title:
Crinetics Pharmaceuticals

Sector:
Healthcare
Industry:
Biotechnology
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.
Do you need help or have a question?
Contact Us